Cargando…
Preclinical concepts and results with the GABA(A) antagonist S44819 in a mouse model of middle cerebral artery occlusion
Autores principales: | Hermann, Dirk M., Saba, Barbara, Sors, Aurore, Bassetti, Claudio L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557109/ https://www.ncbi.nlm.nih.gov/pubmed/31089046 http://dx.doi.org/10.4103/1673-5374.255963 |
Ejemplares similares
-
Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study
por: Chabriat, Hugues, et al.
Publicado: (2020) -
Restoration of GABA(B) receptor expression in cerebral ischemia: a promising novel neuroprotective strategy
por: Bhat, Musadiq A., et al.
Publicado: (2023) -
Postacute Delivery of GABA(A) α5 Antagonist Promotes Postischemic Neurological Recovery and Peri-infarct Brain Remodeling
por: Wang, Ya-chao, et al.
Publicado: (2018) -
Mouse Model of Middle Cerebral Artery Occlusion
por: Chiang, Terrance, et al.
Publicado: (2011) -
Successful Mechanical Thrombectomy of a Middle Cerebral Artery Occlusion 14 Hours after Stroke Onset
por: Dietmann, Anelia, et al.
Publicado: (2017)